Dr. Feinstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1267 Highway 54 W
Ste 4200
Fayetteville, GA 30214Phone+1 678-829-1060Fax+1 678-298-3254
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2006 - 2009- UPMC Medical EducationResidency, Internal Medicine, 2003 - 2006
University of Illinois College of MedicineClass of 2003
Certifications & Licensure
GA State Medical License 2011 - 2026
FL State Medical License 2009 - 2013
PA State Medical License 2003 - 2012- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2012
Clinical Trials
- Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer Start of enrollment: 2015 Aug 24
- Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC Start of enrollment: 2015 Dec 01
- Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC Start of enrollment: 2017 Jun 29
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPlinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, inter...Baohui Han, Trevor Feinstein, Yuankai Shi, Gongyan Chen, Yu Yao
The Lancet. Respiratory Medicine. 2024-10-01 - 26 citationsTrilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer:...Renata Ferrarotto, Ian Anderson, Balazs Medgyasszay, Maria Rosario García-Campelo, William Jeffery Edenfield
Cancer Medicine. 2021-09-01 - 16 citationsPhase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignanciesAthanassios Argiris, T. M. Feinstein, Lin Wang, Tianbing Yang, Shruti Agrawal
Investigational New Drugs. 2012-08-01
Press Mentions
BeyondSpring Delivers Oral Presentation at ISLAC 2024 World Conference on Lung Cancer of Its Lead Anti-Cancer Asset Plinabulin Showcasing Positive Final Phase 3 Data in 2L/3L NSCLC EGFR Wild-Type with Concurrent Publication in the Lancet Respiratory MedicineSeptember 10th, 2024- Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLCSeptember 10th, 2024
- BeyondSpring Announces Oral Presentation at the 2024 World Conference on Lung Cancer and Two Poster Presentations During ESMO Congress 2024 Showcasing Its Lead Anti-Cancer Asset, PlinabulinSeptember 3rd, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
